Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 19 entries
Sorted by: Best Match Show Resources per page
Retention of the capacity to produce plants from protoplasts in cryopreserved cell lines of rice (Oryza sativa L.).

Plant cell reports

Meijer EG, van Iren F, Schrijnemakers E, Hensgens LA, van Zijderveld M, Schilperoort RA.
PMID: 24221539
Plant Cell Rep. 1991 Jul;10(4):171-4. doi: 10.1007/BF00234288.

A method is described for cryopreservation of cell suspension lines of rice (Oryza sativa L.) for use in protoplast research and as a way of retaining desirable characteristics of cell lines. The procedure involves pre-culture with mannitol, addition of...

Cite
Meijer EG, van Iren F, Schrijnemakers E, et al. Retention of the capacity to produce plants from protoplasts in cryopreserved cell lines of rice (Oryza sativa L.). Plant Cell Rep. 1991;10(4):171-4doi: 10.1007/BF00234288.
Meijer, E. G., van Iren, F., Schrijnemakers, E., Hensgens, L. A., van Zijderveld, M., & Schilperoort, R. A. (1991). Retention of the capacity to produce plants from protoplasts in cryopreserved cell lines of rice (Oryza sativa L.). Plant cell reports, 10(4), 171-4. https://doi.org/10.1007/BF00234288
Meijer, E G, et al. "Retention of the capacity to produce plants from protoplasts in cryopreserved cell lines of rice (Oryza sativa L.)." Plant cell reports vol. 10,4 (1991): 171-4. doi: https://doi.org/10.1007/BF00234288
Meijer EG, van Iren F, Schrijnemakers E, Hensgens LA, van Zijderveld M, Schilperoort RA. Retention of the capacity to produce plants from protoplasts in cryopreserved cell lines of rice (Oryza sativa L.). Plant Cell Rep. 1991 Jul;10(4):171-4. doi: 10.1007/BF00234288. PMID: 24221539.
Copy Download .nbib Format: NLM
Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case-Control Study.

Frontiers in cardiovascular medicine

Kleinegris MF, Konings J, Daemen JW, Henskens Y, de Laat B, Spronk HMH, Ten Cate-Hoek AJ, Ten Cate H.
PMID: 28473975
Front Cardiovasc Med. 2017 Apr 20;4:23. doi: 10.3389/fcvm.2017.00023. eCollection 2017.

BACKGROUND: In peripheral arterial disease (PAD), activation of the hemostatic system may contribute to atherosclerosis progression and atherothrombotic events.OBJECTIVE: This case-control study assesses the overall coagulation status in PAD patients by evaluating coagulation markers in combination with thrombin generation...

Cite
Kleinegris MF, Konings J, Daemen JW, et al. Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case-Control Study. Front Cardiovasc Med. 2017;4:23doi: 10.3389/fcvm.2017.00023.
Kleinegris, M. F., Konings, J., Daemen, J. W., Henskens, Y., de Laat, B., Spronk, H. M. H., Ten Cate-Hoek, A. J., & Ten Cate, H. (2017). Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case-Control Study. Frontiers in cardiovascular medicine, 423. https://doi.org/10.3389/fcvm.2017.00023
Kleinegris, Marie-Claire F, et al. "Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case-Control Study." Frontiers in cardiovascular medicine vol. 4 (2017): 23. doi: https://doi.org/10.3389/fcvm.2017.00023
Kleinegris MF, Konings J, Daemen JW, Henskens Y, de Laat B, Spronk HMH, Ten Cate-Hoek AJ, Ten Cate H. Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case-Control Study. Front Cardiovasc Med. 2017 Apr 20;4:23. doi: 10.3389/fcvm.2017.00023. eCollection 2017. PMID: 28473975; PMCID: PMC5397513.
Copy Download .nbib Format: NLM
A Phase I study of the safety, pharmacokinetics and efficacy of navitoclax plus docetaxel in patients with advanced solid tumors.

Future oncology (London, England)

Puglisi M, Molife LR, de Jonge MJ, Khan KH, Doorn LV, Forster MD, Blanco M, Gutierrez M, Franklin C, Busman T, Yang J, Eskens FA.
PMID: 33849298
Future Oncol. 2021 Jul;17(21):2747-2758. doi: 10.2217/fon-2021-0140. Epub 2021 Apr 14.

No abstract available.

Cite
Puglisi M, Molife LR, de Jonge MJ, et al. A Phase I study of the safety, pharmacokinetics and efficacy of navitoclax plus docetaxel in patients with advanced solid tumors. Future Oncol. 2021;17(21):2747-2758doi: 10.2217/fon-2021-0140.
Puglisi, M., Molife, L. R., de Jonge, M. J., Khan, K. H., Doorn, L. V., Forster, M. D., Blanco, M., Gutierrez, M., Franklin, C., Busman, T., Yang, J., & Eskens, F. A. (2021). A Phase I study of the safety, pharmacokinetics and efficacy of navitoclax plus docetaxel in patients with advanced solid tumors. Future oncology (London, England), 17(21), 2747-2758. https://doi.org/10.2217/fon-2021-0140
Puglisi, Martina, et al. "A Phase I study of the safety, pharmacokinetics and efficacy of navitoclax plus docetaxel in patients with advanced solid tumors." Future oncology (London, England) vol. 17,21 (2021): 2747-2758. doi: https://doi.org/10.2217/fon-2021-0140
Puglisi M, Molife LR, de Jonge MJ, Khan KH, Doorn LV, Forster MD, Blanco M, Gutierrez M, Franklin C, Busman T, Yang J, Eskens FA. A Phase I study of the safety, pharmacokinetics and efficacy of navitoclax plus docetaxel in patients with advanced solid tumors. Future Oncol. 2021 Jul;17(21):2747-2758. doi: 10.2217/fon-2021-0140. Epub 2021 Apr 14. PMID: 33849298.
Copy Download .nbib Format: NLM
The Influence of Prostaglandin E1 and Use of Inhibitor Percentage on the Correlation between the Multiplate and VerifyNow in Patients on Dual Antiplatelet Therapy.

Platelets

Hulshof AM, Vries M, Verhezen P, Wetzels R, Haartmans M, Olie R, Ten Cate H, Henskens Y.
PMID: 32314928
Platelets. 2021 May 19;32(4):463-468. doi: 10.1080/09537104.2020.1754378. Epub 2020 Apr 21.

Platelet function tests (PFT), such as the Multiple Electrode Analyzer (Multiplate) and VerifyNow, show little concordance in patients using antiplatelet drugs. A major difference between these tests is the use of prostaglandin E1 (PGE1) to inhibit P2Y1-platelet-receptor activation in...

Cite
Hulshof AM, Vries M, Verhezen P, et al. The Influence of Prostaglandin E1 and Use of Inhibitor Percentage on the Correlation between the Multiplate and VerifyNow in Patients on Dual Antiplatelet Therapy. Platelets. 2020;32(4):463-468doi: 10.1080/09537104.2020.1754378.
Hulshof, A. M., Vries, M., Verhezen, P., Wetzels, R., Haartmans, M., Olie, R., Ten Cate, H., & Henskens, Y. (2021). The Influence of Prostaglandin E1 and Use of Inhibitor Percentage on the Correlation between the Multiplate and VerifyNow in Patients on Dual Antiplatelet Therapy. Platelets, 32(4), 463-468. https://doi.org/10.1080/09537104.2020.1754378
Hulshof, Anne-Marije, et al. "The Influence of Prostaglandin E1 and Use of Inhibitor Percentage on the Correlation between the Multiplate and VerifyNow in Patients on Dual Antiplatelet Therapy." Platelets vol. 32,4 (2021): 463-468. doi: https://doi.org/10.1080/09537104.2020.1754378
Hulshof AM, Vries M, Verhezen P, Wetzels R, Haartmans M, Olie R, Ten Cate H, Henskens Y. The Influence of Prostaglandin E1 and Use of Inhibitor Percentage on the Correlation between the Multiplate and VerifyNow in Patients on Dual Antiplatelet Therapy. Platelets. 2021 May 19;32(4):463-468. doi: 10.1080/09537104.2020.1754378. Epub 2020 Apr 21. PMID: 32314928.
Copy Download .nbib Format: NLM
Results of Coarctation Repair by Thoracotomy in Pediatric Patients: A Single Institution Experience.

World journal for pediatric & congenital heart surgery

Heremans L, Henkens A, de Beco G, Carbonez K, Moniotte S, Rubay JE, Momeni M, Houtekie L, Poncelet AJ.
PMID: 34278865
World J Pediatr Congenit Heart Surg. 2021 Jul;12(4):492-499. doi: 10.1177/21501351211003505.

BACKGROUND: Aortic coarctation is among the most common cardiovascular congenital abnormalities requiring repair after birth. Besides mortality, morbidity remains an important aspect. Accordingly, we reviewed our 20-year experience of aortic coarctation repair by thoracotomy, with emphasis on both short-...

Cite
Heremans L, Henkens A, de Beco G, et al. Results of Coarctation Repair by Thoracotomy in Pediatric Patients: A Single Institution Experience. World J Pediatr Congenit Heart Surg. 2021;12(4):492-499doi: 10.1177/21501351211003505.
Heremans, L., Henkens, A., de Beco, G., Carbonez, K., Moniotte, S., Rubay, J. E., Momeni, M., Houtekie, L., & Poncelet, A. J. (2021). Results of Coarctation Repair by Thoracotomy in Pediatric Patients: A Single Institution Experience. World journal for pediatric & congenital heart surgery, 12(4), 492-499. https://doi.org/10.1177/21501351211003505
Heremans, Louis, et al. "Results of Coarctation Repair by Thoracotomy in Pediatric Patients: A Single Institution Experience." World journal for pediatric & congenital heart surgery vol. 12,4 (2021): 492-499. doi: https://doi.org/10.1177/21501351211003505
Heremans L, Henkens A, de Beco G, Carbonez K, Moniotte S, Rubay JE, Momeni M, Houtekie L, Poncelet AJ. Results of Coarctation Repair by Thoracotomy in Pediatric Patients: A Single Institution Experience. World J Pediatr Congenit Heart Surg. 2021 Jul;12(4):492-499. doi: 10.1177/21501351211003505. PMID: 34278865.
Copy Download .nbib Format: NLM
Synthesis and complete NMR spectral assignment of thiophene-substituted sulfinyl monomers.

Magnetic resonance in chemistry : MRC

Henckens A, Adriaensens P, Gelan J, Lutsen L, Vanderzande D.
PMID: 15372616
Magn Reson Chem. 2004 Nov;42(11):931-7. doi: 10.1002/mrc.1455.

This paper describes the synthesis of thiophene-substituted sulfinyl monomers. It comprises a four-step reaction by which the thiophene unit is built in via Suzuki coupling. These monomers could be used as building blocks for the preparation of conducting polymers...

Cite
Henckens A, Adriaensens P, Gelan J, et al. Synthesis and complete NMR spectral assignment of thiophene-substituted sulfinyl monomers. Magn Reson Chem. 2004;42(11):931-7doi: 10.1002/mrc.1455.
Henckens, A., Adriaensens, P., Gelan, J., Lutsen, L., & Vanderzande, D. (2004). Synthesis and complete NMR spectral assignment of thiophene-substituted sulfinyl monomers. Magnetic resonance in chemistry : MRC, 42(11), 931-7. https://doi.org/10.1002/mrc.1455
Henckens, Anja, et al. "Synthesis and complete NMR spectral assignment of thiophene-substituted sulfinyl monomers." Magnetic resonance in chemistry : MRC vol. 42,11 (2004): 931-7. doi: https://doi.org/10.1002/mrc.1455
Henckens A, Adriaensens P, Gelan J, Lutsen L, Vanderzande D. Synthesis and complete NMR spectral assignment of thiophene-substituted sulfinyl monomers. Magn Reson Chem. 2004 Nov;42(11):931-7. doi: 10.1002/mrc.1455. PMID: 15372616.
Copy Download .nbib Format: NLM
Current and Novel Treatment Options for Metastatic Colorectal Cancer: Emphasis on Aflibercept.

Biologics in therapy

Dietvorst MH, Eskens FA.
PMID: 24392302
Biol Ther. 2013;3:25-33. doi: 10.1007/s13554-013-0009-6. Epub 2013 Feb 28.

Worldwide, colorectal cancer (CRC) is the third most frequently diagnosed cancer in men and the second in women. Metastatic disease develops in more than half of the patients and carries a poor prognosis. Over the past three decades, significant...

Cite
Dietvorst MH, Eskens FA. Current and Novel Treatment Options for Metastatic Colorectal Cancer: Emphasis on Aflibercept. Biol Ther. 2013;3:25-33doi: 10.1007/s13554-013-0009-6.
Dietvorst, M. H., & Eskens, F. A. (2013). Current and Novel Treatment Options for Metastatic Colorectal Cancer: Emphasis on Aflibercept. Biologics in therapy, 325-33. https://doi.org/10.1007/s13554-013-0009-6
Dietvorst, Maria H P, and Eskens, Ferry A L M. "Current and Novel Treatment Options for Metastatic Colorectal Cancer: Emphasis on Aflibercept." Biologics in therapy vol. 3 (2013): 25-33. doi: https://doi.org/10.1007/s13554-013-0009-6
Dietvorst MH, Eskens FA. Current and Novel Treatment Options for Metastatic Colorectal Cancer: Emphasis on Aflibercept. Biol Ther. 2013;3:25-33. doi: 10.1007/s13554-013-0009-6. Epub 2013 Feb 28. PMID: 24392302; PMCID: PMC3873022.
Copy Download .nbib Format: NLM
Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity.

Thrombosis journal

Kuiper GJ, Kleinegris MC, van Oerle R, Spronk HM, Lancé MD, Ten Cate H, Henskens YM.
PMID: 26770073
Thromb J. 2016 Jan 14;14:1. doi: 10.1186/s12959-016-0076-2. eCollection 2016.

BACKGROUND: Thus far, validated whole blood assays used in in vitro fibrinolysis experiments using thromboelastometry (ROTEM) are lacking or have yet to be tested in humans. The objective was first, to establish a standardized modified ROTEM approach to detect...

Cite
Kuiper GJ, Kleinegris MC, van Oerle R, et al. Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity. Thromb J. 2016;14:1doi: 10.1186/s12959-016-0076-2.
Kuiper, G. J., Kleinegris, M. C., van Oerle, R., Spronk, H. M., Lancé, M. D., Ten Cate, H., & Henskens, Y. M. (2016). Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity. Thrombosis journal, 141. https://doi.org/10.1186/s12959-016-0076-2
Kuiper, Gerhardus J A J M, et al. "Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity." Thrombosis journal vol. 14 (2016): 1. doi: https://doi.org/10.1186/s12959-016-0076-2
Kuiper GJ, Kleinegris MC, van Oerle R, Spronk HM, Lancé MD, Ten Cate H, Henskens YM. Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity. Thromb J. 2016 Jan 14;14:1. doi: 10.1186/s12959-016-0076-2. eCollection 2016. PMID: 26770073; PMCID: PMC4712545.
Copy Download .nbib Format: NLM
Techniques for Improving Communication of Emotional Content in Text-Only Web-Based Therapeutic Communications: Systematic Review.

JMIR mental health

Paul CL, Cox ME, Small HJ, Boyes AW, O'Brien L, Rose SK, Baker AL, Henskens FA, Kirkwood HN, Roach DM.
PMID: 29066426
JMIR Ment Health. 2017 Oct 24;4(4):e46. doi: 10.2196/mental.6707.

BACKGROUND: Web-based typed exchanges are increasingly used by professionals to provide emotional support to patients. Although some empirical evidence exists to suggest that various strategies may be used to convey emotion during Web-based text communication, there has been no...

Cite
Paul CL, Cox ME, Small HJ, et al. Techniques for Improving Communication of Emotional Content in Text-Only Web-Based Therapeutic Communications: Systematic Review. JMIR Ment Health. 2017;4(4):e46doi: 10.2196/mental.6707.
Paul, C. L., Cox, M. E., Small, H. J., Boyes, A. W., O'Brien, L., Rose, S. K., Baker, A. L., Henskens, F. A., Kirkwood, H. N., & Roach, D. M. (2017). Techniques for Improving Communication of Emotional Content in Text-Only Web-Based Therapeutic Communications: Systematic Review. JMIR mental health, 4(4), e46. https://doi.org/10.2196/mental.6707
Paul, Christine Louise, et al. "Techniques for Improving Communication of Emotional Content in Text-Only Web-Based Therapeutic Communications: Systematic Review." JMIR mental health vol. 4,4 (2017): e46. doi: https://doi.org/10.2196/mental.6707
Paul CL, Cox ME, Small HJ, Boyes AW, O'Brien L, Rose SK, Baker AL, Henskens FA, Kirkwood HN, Roach DM. Techniques for Improving Communication of Emotional Content in Text-Only Web-Based Therapeutic Communications: Systematic Review. JMIR Ment Health. 2017 Oct 24;4(4):e46. doi: 10.2196/mental.6707. PMID: 29066426; PMCID: PMC5676033.
Copy Download .nbib Format: NLM
Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype.

Journal of extracellular vesicles

Vajen T, Benedikter BJ, Heinzmann ACA, Vasina EM, Henskens Y, Parsons M, Maguire PB, Stassen FR, Heemskerk JWM, Schurgers LJ, Koenen RR.
PMID: 28717419
J Extracell Vesicles. 2017 May 16;6(1):1322454. doi: 10.1080/20013078.2017.1322454. eCollection 2017.

Extracellular vesicles (EVs) are mediators of cell communication during health and disease, and abundantly released by platelets upon activation or during ageing. Platelet EVs exert modulatory effects on immune and vascular cells. Platelet EVs may modulate the function of...

Cite
Vajen T, Benedikter BJ, Heinzmann ACA, et al. Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype. J Extracell Vesicles. 2017;6(1):1322454doi: 10.1080/20013078.2017.1322454.
Vajen, T., Benedikter, B. J., Heinzmann, A. C. A., Vasina, E. M., Henskens, Y., Parsons, M., Maguire, P. B., Stassen, F. R., Heemskerk, J. W. M., Schurgers, L. J., & Koenen, R. R. (2017). Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype. Journal of extracellular vesicles, 6(1), 1322454. https://doi.org/10.1080/20013078.2017.1322454
Vajen, Tanja, et al. "Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype." Journal of extracellular vesicles vol. 6,1 (2017): 1322454. doi: https://doi.org/10.1080/20013078.2017.1322454
Vajen T, Benedikter BJ, Heinzmann ACA, Vasina EM, Henskens Y, Parsons M, Maguire PB, Stassen FR, Heemskerk JWM, Schurgers LJ, Koenen RR. Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype. J Extracell Vesicles. 2017 May 16;6(1):1322454. doi: 10.1080/20013078.2017.1322454. eCollection 2017. PMID: 28717419; PMCID: PMC5505004.
Copy Download .nbib Format: NLM
Getting the right fit: Convergence between preferred and perceived involvement in treatment decision making among medical oncology outpatients.

Health science reports

Mansfield E, Bryant J, Carey M, Turon H, Henskens F, Grady A.
PMID: 30697595
Health Sci Rep. 2018 Nov 06;2(1):e101. doi: 10.1002/hsr2.101. eCollection 2019 Jan.

BACKGROUND AND AIMS: While cancer patients' preferences for their level of involvement in treatment decision making (TDM) vary, previous research indicates a large proportion of patients are not experiencing TDM that meets their preferences. Evidence is needed to identify...

Cite
Mansfield E, Bryant J, Carey M, et al. Getting the right fit: Convergence between preferred and perceived involvement in treatment decision making among medical oncology outpatients. Health Sci Rep. 2018;2(1):e101doi: 10.1002/hsr2.101.
Mansfield, E., Bryant, J., Carey, M., Turon, H., Henskens, F., & Grady, A. (2019). Getting the right fit: Convergence between preferred and perceived involvement in treatment decision making among medical oncology outpatients. Health science reports, 2(1), e101. https://doi.org/10.1002/hsr2.101
Mansfield, Elise, et al. "Getting the right fit: Convergence between preferred and perceived involvement in treatment decision making among medical oncology outpatients." Health science reports vol. 2,1 (2019): e101. doi: https://doi.org/10.1002/hsr2.101
Mansfield E, Bryant J, Carey M, Turon H, Henskens F, Grady A. Getting the right fit: Convergence between preferred and perceived involvement in treatment decision making among medical oncology outpatients. Health Sci Rep. 2018 Nov 06;2(1):e101. doi: 10.1002/hsr2.101. eCollection 2019 Jan. PMID: 30697595; PMCID: PMC6346985.
Copy Download .nbib Format: NLM
Development of novel membranes for blood purification therapies based on copolymers of N-vinylpyrrolidone and n-butylmethacrylate.

Journal of materials chemistry. B

Tijink M, Janssen J, Timmer M, Austen J, Aldenhoff Y, Kooman J, Koole L, Damoiseaux J, van Oerle R, Henskens Y, Stamatialis D.
PMID: 32260991
J Mater Chem B. 2013 Nov 28;1(44):6066-6077. doi: 10.1039/c3tb20964d. Epub 2013 Oct 07.

Developments in membrane based blood purification therapies often come with longer treatment times and therefore longer blood-material contact, which requires long-term membrane biocompatibility. In this study, we develop for the first time membranes for blood purification using the material...

Cite
Tijink M, Janssen J, Timmer M, et al. Development of novel membranes for blood purification therapies based on copolymers of N-vinylpyrrolidone and n-butylmethacrylate. J Mater Chem B. 2013;1(44):6066-6077doi: 10.1039/c3tb20964d.
Tijink, M., Janssen, J., Timmer, M., Austen, J., Aldenhoff, Y., Kooman, J., Koole, L., Damoiseaux, J., van Oerle, R., Henskens, Y., & Stamatialis, D. (2013). Development of novel membranes for blood purification therapies based on copolymers of N-vinylpyrrolidone and n-butylmethacrylate. Journal of materials chemistry. B, 1(44), 6066-6077. https://doi.org/10.1039/c3tb20964d
Tijink, M, et al. "Development of novel membranes for blood purification therapies based on copolymers of N-vinylpyrrolidone and n-butylmethacrylate." Journal of materials chemistry. B vol. 1,44 (2013): 6066-6077. doi: https://doi.org/10.1039/c3tb20964d
Tijink M, Janssen J, Timmer M, Austen J, Aldenhoff Y, Kooman J, Koole L, Damoiseaux J, van Oerle R, Henskens Y, Stamatialis D. Development of novel membranes for blood purification therapies based on copolymers of N-vinylpyrrolidone and n-butylmethacrylate. J Mater Chem B. 2013 Nov 28;1(44):6066-6077. doi: 10.1039/c3tb20964d. Epub 2013 Oct 07. PMID: 32260991.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 19 entries